Akcea Therapeutics (AKCA) Tops Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall St choppy as megacap losses offset chip gains before Fed decision
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise about 2% as Yemen fighting stokes supply fears
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
- S&P Global explores potential separation of Capital IQ business
- Wall Street ends higher on revived AI momentum
- SpaceX stock drops amid spaceport lawsuit, debt concerns
- Nebius Group shares jump after France data center funding
- GE Vernova Inc. (GEV) Tops Q3 EPS by 81c, Beats on Revenue; Offers FY26 Revenue Guidance
Akcea Reports Financial Results and Highlights for Third Quarter 2018
November 5, 2018 4:05 PM ESTTEGSEDITM (inotersen) Approved in United States, European Union & Canada    Â
$320 million to fund the company through key milestones
Conference Call Webcast Monday, November 5, 4:30 p.m. ET at www.akceatx.com
BOSTON, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:... More



